Hypertension and low cholesterol as risk factors for infection after primary inflatable penile prosthesis surgery

Background: Inflatable penile prosthesis (IPP) is an effective surgical intervention in the treatment of erectile dysfunction. However, infection is a devastating complication of IPP placement. We sought to evaluate the association between medical comorbidities, medications, and serum metabolic lab values, and infection following primary IPP placement in our ethnically diverse population. Methods: A retrospective chart review was performed on all men who had primary IPP placement between 2017–2019 at our institution. Variables collected included patient demographics, medical history, medication usage, and pre- and postoperative lab values, within six months of surgery, including hemoglobin A1c, total cholesterol, and low density lipoprotein. Rates of postoperative infection through 60 days were noted. Patients were grouped either into the infected or non-infected cohort based on postoperative infection status. A Student’s unpaired t-test was used to compare numerical variables and a Pearson chi-square test or Fisher’s exact test was used to compare categorical variables between the cohorts. Results: A total of 293 men underwent primary IPP placement, of whom 14 (4.8%) were in the infected cohort and 279 (95.2%) in the non-infected cohort. The infected cohort was more likely to have a history of hypertension (92.9% vs 74.2%, p = 0.026) and statins medication usage (78.6% vs 52.0%, p = 0.039) when compared to the non-infected cohort, respectively. The infected cohort had a significantly lower postoperative cholesterol value (136.3 mg/dL vs 170.0 mg/dL, p = 0.024) and postoperative low density lipoprotein (LDL) value (65.2 mg/dL vs 92.1 mg/dL, p = 0.020) when compared to the non-infected cohort, respectively. Conclusions: Hypertension and usage of statin medications were more common in men who developed infection following IPP placement. As hypertension can disrupt microvasculature over time, it may contribute to poor healing post-IPP placement. Future research is warranted to determine statins’ anti-inflammatory effect on wound healing and ability to fight infection.

erectile; implant; prosthesis; infection; inflatable; risk

[1] Shamloul R, Ghanem H. Erectile dysfunction. The Lancet. 2013; 381: 153–165.

[2] Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moin-pour CM, Coltman CA. Erectile dysfunction and subsequent car-diovascular disease. The Journal of the American Medical As-sociation. 2005; 294: 2996–3002.

[3] Elterman DS, Bhattacharyya SK, Mafilios M, Woodward E, Nitschelm K, Burnett AL. The Quality of Life and Economic Burden of Erectile Dysfunction. Research and Reports in Urol-ogy. 2021; 13: 79–86.

[4] Chung E, Van CT, Wilson I, Cartmill RA. Penile prosthesis im-plantation for the treatment for male erectile dysfunction: clin-ical outcomes and lessons learnt after 955 procedures. World Journal of Urology. 2013; 31: 591–595.

[5] Rodriguez KM, Kohn TP, Davis AB, Hakky TS. Penile im-plants: a look into the future. Translational Andrology and Urol-ogy. 2017; 6: S860–S866.

[6] Carrasquillo RJ, Munarriz RM, Gross MS. Infection Prevention Considerations for Complex Penile Prosthesis Recipients. Cur-rent Urology Reports. 2019; 20: 12.

[7] Gon LM, de Campos CCC, Voris BRI, Passeri LA, Fregonesi A, Riccetto CLZ. A systematic review of penile prosthesis infec-tion and meta-analysis of diabetes mellitus role. BMC Urology. 2021; 21: 35.

[8] Raheem OA, Hsieh TC. Penile prosthetic surgery for the man-agement of Peyronie’s disease. Translational Andrology and Urology. 2017; 6: S815–S821.

[9] Hebert KJ, Kohler TS. Penile Prosthesis Infection: Myths and Realities. The World Journal of Men’s Health. 2019; 37: 276–287.

[10] Eid JF, Wilson SK, Cleves M, Salem EA. Coated Implants and “no Touch” Surgical Technique Decreases Risk of Infection in Inflatable Penile Prosthesis Implantation to 0.46%. Urology. 2012; 79: 1310–1315.

[11] Çakan M, Demirel F, Karabacak O, Yalçınkaya F, Altuğ U. Risk factors for penile prosthetic infection. International Urology and Nephrology. 2003; 35: 209–213.

[12] Carvajal A, Benavides J, García-Perdomo HA, Henry GD. Risk factors associated with penile prosthesis infection: systematic review and meta-analysis. International Journal of Impotence Research. 2020; 32: 587–597.

[13] Otero JR, Manfredi C, Wilson SK. The good, the bad, and the ugly about surgical approaches for inflatable penile prosthe-sis implantation. International Journal of Impotence Research. 2020. (in press)

[14] Gross MS, Phillips EA, Carrasquillo RJ, Thornton A, Greenfield JM, Levine LA, et al. Multicenter Investigation of the Micro-

Organisms Involved in Penile Prosthesis Infection: an Analysis of the Efficacy of the AUA and EAU Guidelines for Penile Pros-thesis Prophylaxis. The Journal of Sexual Medicine. 2017; 14: 455–463.

[15] Safar ME, Rizzoni D, Blacher J, Muiesan ML, Agabiti-Rosei E. Macro and microvasculature in hypertension: therapeutic as-pects. Journal of Human Hypertension. 2008; 22: 590–595.

[16] Gould AL, Davies GM, Alemao E, Yin DD, Cook JR. Choles-terol reduction yields clinical benefits: meta-analysis including recent trials. Clinical Therapeutics. 2007; 29: 778–794.

[17] Strandberg TE, Strandberg A, Rantanen K, Salomaa VV, Pitkälä K, Miettinen TA. Low cholesterol, mortality, and quality of life in old age during a 39-year follow-up. Journal of the American College of Cardiology. 2004; 44: 1002–1008.

[18] Bagnati M, Moreno-Moral A, Ko J, Nicod J, Harmston N, Impri-alou M, et al. Systems genetics identifies a macrophage choles-terol network associated with physiological wound healing. JCI Insight. 2019; 4: e125736.

[19] Morimoto M, Nakamura Y, Yasuda Y, Lefor AT, Nagaie T, Sata N, et al. Serum Total Cholesterol Levels would Predict Nosoco-mial Infections after Gastrointestinal Surgery. The Indian Jour-nal of Surgery. 2015; 77: 283–289.

[20] Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. The Lancet. 2000; 356: 930–933.

[21] Farsaei S, Khalili H, Farboud ES. Potential role of statins on wound healing: review of the literature. International Wound Journal. 2012; 9: 238–247.

[22] Zeiser R. Immune modulatory effects of statins. Immunology. 2018; 154: 69–75.